YorkBridge Wealth Partners’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $309K | Sell |
2,589
-765
| -23% | -$91.4K | 0.08% | 184 |
|
|
2022
Q3 | $356K | Sell |
3,354
-215
| -6% | -$22.8K | 0.09% | 160 |
|
|
2022
Q2 | $348K | Sell |
3,569
-554
| -13% | -$54K | 0.09% | 170 |
|
|
2022
Q1 | $387K | Buy |
4,123
+1,411
| +52% | +$132K | 0.08% | 184 |
|
|
2021
Q4 | $231K | Sell |
2,712
-1,019
| -27% | -$86.8K | 0.05% | 261 |
|
|
2021
Q3 | $358K | Buy |
3,731
+679
| +22% | +$65.2K | 0.09% | 193 |
|
|
2021
Q2 | $297K | Buy |
3,052
+148
| +5% | +$14.4K | 0.08% | 208 |
|
|
2021
Q1 | $282K | Buy |
+2,904
| New | +$282K | 0.08% | 210 |
|